Home Article ASP: Budesonide takes a dive

ASP: Budesonide takes a dive

ASP: Budesonide takes a dive

Also Noted

Default Author Head Shot

By HME News Staff

Updated Wed April 6, 2016

BALTIMORE - Second quarter payments for respiratory drugs are up in most cases, with the exception of Budesonide (J7626), which decreased sharply, down nearly 73 cents per dose. Perforomist (J7606) saw the biggest increase, up 41 cents to $9.82 per dose, according to the latest average sales price (ASP) figures. Brovana (J7605) increased 24 cents to $8.50 per dose. Albuterol (J7613) and ipratropium (J7644) stayed fairly flat, at 12.5 cents per dose and 10.5 cents per dose, respectively.

Comments

To comment on this post, please log in to your account or set up an account now.